Table 3.
Model | Dependent Variable | n | Variable | Estimate | p-value | Odds Ratio (CI) | C Statistic |
---|---|---|---|---|---|---|---|
1 | Urinary Severity | 377 | Urinary Severity at Baseline | 0.140 | <.0001 | 1.151 (1.104–1.199) | 0.711 |
Duration of symptom: 0:<2yr,1:>=2yrs | −0.420 | 0.060 | 0.657 (0.424–1.017) | ||||
SF12 - PCS (Duration < 2yrs) | 0.068 | <.0001 | 1.070 (1.032–1.110) | ||||
SF12 - PCS (Duration ≥ 2yrs) | 0.013 | 0.374 | 1.013 (0.985–1.041) | ||||
2 | Urinary Severity | 397 | Urinary Severity at Baseline | 0.132 | <.0001 | 1.141 (1.099–1.185) | 0.714 |
Duration of symptom: 0:<2yr,1:>=2yrs | −0.508 | 0.021 | 0.602 (0.392–0.925) | ||||
BPI Sites, Non-pelvic (Duration < 2yrs) | −0.113 | <.0001 | 0.893 (0.845–0.944) | ||||
BPI Sites, Non-pelvic (Duration ≥ 2yrs) | −0.013 | 0.595 | 0.987 (0.942–1.035) |
SF12 PCS and BPI sites variables were centered prior to analysis to facilitate interpretation of the direction of the interactions.